Login / Signup

Effectiveness of tigecycline in the treatment of infections caused by carbapenem-resistant gram-negative bacteria in pediatric liver transplant recipients: A retrospective study.

Fang ChenChuan ShenXiaoyun PangZaili ZhangYuxiao DengLongzhi HanXiaosong ChenJianjun ZhangQiang XiaYong-Bing Qian
Published in: Transplant infectious disease : an official journal of the Transplantation Society (2019)
Tigecycline can be considered in combination antimicrobial regimen for treating CRGNB-related infections in pediatric liver transplant recipients.
Keyphrases
  • acinetobacter baumannii
  • klebsiella pneumoniae
  • randomized controlled trial
  • systematic review
  • escherichia coli
  • combination therapy
  • cystic fibrosis